Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1995 Jul;50(7):712–718. doi: 10.1136/thx.50.7.712

Long term prognosis of patients with cystic fibrosis in relation to early detection by neonatal screening and treatment in a cystic fibrosis centre.

J E Dankert-Roelse 1, G J te Meerman 1
PMCID: PMC474641  PMID: 7570403

Abstract

BACKGROUND--A study was undertaken to evaluate whether an early diagnosis by neonatal screening may improve the long term prognosis of patients with cystic fibrosis and to assess the influence of expert management started immediately after the diagnosis. METHODS--Comparative clinical follow up in three birth cohorts of patients with cystic fibrosis was performed at the Cystic Fibrosis centre in Groningen in close collaboration with paediatricians in general hospitals in the north-eastern part of the Netherlands. The first birth cohort (n = 19) was detected by screening and the two other cohorts were detected clinically, one (n = 30) consisting of patients born during the screening programme and the other (n = 32) of patients born during the six years immediately after the screening programme ended. The total number of patients in the three birth cohorts included all patients with cystic fibrosis born in this area during a 12 year period. Cumulative survival rates and the variation with time of lung function, the levels of immunoglobulins, and growth patterns were used as main outcome measures. RESULTS--Patients born during the screening programme but detected clinically appeared to have a reduced life expectancy compared with patients detected by screening. The patients detected by screening showed less deterioration in lung function (annual decrease 1.2% of FEV1 % pred), a smaller increase in immunoglobulin levels, and minimal catch-up growth compared with an annual decrease of 3.25% of FEV1 % pred in the non-screened birth cohort of the same age, a higher rise in immunoglobulins leading to increased levels at the end of the observation period, and catch-up growth for weight as well as height. Differences between patients treated in a cystic fibrosis centre and those not referred to a specialist centre were smaller but similar, in favour of treatment at a cystic fibrosis clinic. CONCLUSIONS--Expert management started immediately after an early diagnosis of cystic fibrosis by neonatal screening results in important beneficial effects on the outcome and clinical course of the condition. The institution of very early treatment may be critical for the outcome and long term prognosis for most patients with cystic fibrosis. Neonatal screening programmes for cystic fibrosis should be introduced more widely.

Full text

PDF
712

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bronstein M. N., Sokol R. J., Abman S. H., Chatfield B. A., Hammond K. B., Hambidge K. M., Stall C. D., Accurso F. J. Pancreatic insufficiency, growth, and nutrition in infants identified by newborn screening as having cystic fibrosis. J Pediatr. 1992 Apr;120(4 Pt 1):533–540. doi: 10.1016/s0022-3476(05)82478-3. [DOI] [PubMed] [Google Scholar]
  2. CUTLER S. J., EDERER F. Maximum utilization of the life table method in analyzing survival. J Chronic Dis. 1958 Dec;8(6):699–712. doi: 10.1016/0021-9681(58)90126-7. [DOI] [PubMed] [Google Scholar]
  3. Corey M., McLaughlin F. J., Williams M., Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol. 1988;41(6):583–591. doi: 10.1016/0895-4356(88)90063-7. [DOI] [PubMed] [Google Scholar]
  4. Cystic fibrosis in the United Kingdom 1977-85: an improving picture. British Paediatric Association Working Party on Cystic Fibrosis. BMJ. 1988 Dec 17;297(6663):1599–1602. doi: 10.1136/bmj.297.6663.1599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dankert-Roelse J. E., te Meerman G. J., Martijn A., ten Kate L. P., Knol K. Screening for cystic fibrosis. A comparative study. Acta Paediatr Scand. 1987 Mar;76(2):209–214. doi: 10.1111/j.1651-2227.1987.tb10449.x. [DOI] [PubMed] [Google Scholar]
  6. Dankert-Roelse J. E., te Meerman G. J., Martijn A., ten Kate L. P., Knol K. Survival and clinical outcome in patients with cystic fibrosis, with or without neonatal screening. J Pediatr. 1989 Mar;114(3):362–367. doi: 10.1016/s0022-3476(89)80552-9. [DOI] [PubMed] [Google Scholar]
  7. Davis P. B. Cystic fibrosis from bench to bedside. N Engl J Med. 1991 Aug 22;325(8):575–577. doi: 10.1056/NEJM199108223250809. [DOI] [PubMed] [Google Scholar]
  8. Elborn J. S., Shale D. J., Britton J. R. Cystic fibrosis: current survival and population estimates to the year 2000. Thorax. 1991 Dec;46(12):881–885. doi: 10.1136/thx.46.12.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Green M. R., Weaver L. T., Heeley A. F., Nicholson K., Kuzemko J. A., Barton D. E., McMahon R., Payne S. J., Austin S., Yates J. R. Cystic fibrosis identified by neonatal screening: incidence, genotype, and early natural history. Arch Dis Child. 1993 Apr;68(4):464–467. doi: 10.1136/adc.68.4.464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hammond K. B., Abman S. H., Sokol R. J., Accurso F. J. Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations. N Engl J Med. 1991 Sep 12;325(11):769–774. doi: 10.1056/NEJM199109123251104. [DOI] [PubMed] [Google Scholar]
  11. Kerem E., Reisman J., Corey M., Canny G. J., Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med. 1992 Apr 30;326(18):1187–1191. doi: 10.1056/NEJM199204303261804. [DOI] [PubMed] [Google Scholar]
  12. Marcus M. S., Sondel S. A., Farrell P. M., Laxova A., Carey P. M., Langhough R., Mischler E. H. Nutritional status of infants with cystic fibrosis associated with early diagnosis and intervention. Am J Clin Nutr. 1991 Sep;54(3):578–585. doi: 10.1093/ajcn/54.3.578. [DOI] [PubMed] [Google Scholar]
  13. Ranieri E., Lewis B. D., Gerace R. L., Ryall R. G., Morris C. P., Nelson P. V., Carey W. F., Robertson E. F. Neonatal screening for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis: four years' experience. BMJ. 1994 Jun 4;308(6942):1469–1472. doi: 10.1136/bmj.308.6942.1469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ranieri E., Ryall R. G., Morris C. P., Nelson P. V., Carey W. F., Pollard A. C., Robertson E. F. Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis. BMJ. 1991 May 25;302(6787):1237–1240. doi: 10.1136/bmj.302.6787.1237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ten Kate L. P., Feenstra-de Gooyer I., Ploeg-de Groot G., Gouw W. L., Anders G. J. Should we screen all newborns for cystic fibrosis? Int J Epidemiol. 1978 Dec;7(4):323–330. doi: 10.1093/ije/7.4.323. [DOI] [PubMed] [Google Scholar]
  16. Ten Kate L. P., Feenstra-de Gooyer I., Ploeg-de Groot G., Gouw W. L., Anders G. J. Should we screen all newborns for cystic fibrosis? Int J Epidemiol. 1978 Dec;7(4):323–330. doi: 10.1093/ije/7.4.323. [DOI] [PubMed] [Google Scholar]
  17. Weaver L. T., Green M. R., Nicholson K., Mills J., Heeley M. E., Kuzemko J. A., Austin S., Gregory G. A., Dux A. E., Davis J. A. Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal period. Arch Dis Child. 1994 Feb;70(2):84–89. doi: 10.1136/adc.70.2.84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Wilcken B., Chalmers G. Reduced morbidity in patients with cystic fibrosis detected by neonatal screening. Lancet. 1985 Dec 14;2(8468):1319–1321. doi: 10.1016/s0140-6736(85)92623-6. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES